Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Paola Coco"'
Autor:
Massimo Breccia, Antonella Russo Rossi, Valentina Giai, Bruno Martino, Carmen Fava, Mario Annunziata, Elisabetta Abruzzese, Gianni Binotto, Claudia Baratè, Aurelio Pio Nardozza, Alessandra Misto, Paola Coco, Valeria Calafiore, Maria Cristina Carraro, Federica Cattina, Francesco Cavazzini, Maria Teresa Corsetti, Lara Crucitti, Monica Crugnola, Paolo Ditonno, Ambra DI Veroli, Anna Ermacora, Felicetto Ferrara, Angelo Genua, Antonella Gozzini, Stefana Impera, Alessandra Iurlo, Luciano Levato, Luigiana Luciano, Maria Cristina Miggiano, Marco De Gobbi, Marco Santoro, Barbara Scappini, Anna Rita Scortechini, Andrea Patriarca, Serena Rosati, Sabina Russo, Rosaria Sancetta, Grazia Sanpaolo, Teresa Maria Santeramo, Silvia Sibilla, Federica Sorà, Paolo Sportoletti, Fabio Stagno, Elena Trabacchi, Fausto Castagnetti
Publikováno v:
HemaSphere, Vol 7, p e55133e1 (2023)
Externí odkaz:
https://doaj.org/article/7ea0bb7830224451ba8d9aae8fc0796c
Autor:
Massimo Breccia, Francesca Chiodi, Aurelio Pio Nardozza, Diletta Valsecchi, Valentina Perrone, Diego Sangiorgi, Elisa Giacomini, Maria Chiara Rendace, Paola Coco, Eleonora Premoli, Luca Degli Esposti
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 13, p 3597 (2022)
Real world data are becoming a crucial tool to understand how cancer is treated in routine daily practice. This real-world analysis aims to describe the characteristics of patients with CML in 2nd or ≥3rd tyrosine kinase inhibitors (TKI) lines of t
Externí odkaz:
https://doaj.org/article/7734b2fcca6048be85269a6987ab1567
Autor:
Alessandro Maria Vannucchi, Andrea Mortara, Andrea D’Alessio, Mara Morelli, Alberto Tedeschi, Moreno Benedetto Festuccia, Antonella D’Arminio Monforte, Enrico Capochiani, Carmine Selleri, Federico Simonetti, Annalisa Saracino, Davide Rapezzi, Maria Rita Badagliacca, Katia Falasca, Alfredo Molteni, Roberto Palazzolo, Giuliano Schettino, Monica Bocchia, Mauro Turrini, Paolo A. Ascierto, Mike Zuurman, Carole Paley, Paola Coco, Giuseppe Saglio
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 16, p 3752 (2021)
Jak inhibitors are potent anti-inflammatory drugs that have the potential to dampen the hyperactive inflammatory response associated with severe COVID-19. We reviewed the clinical outcomes of 218 patients with COVID-19 hospitalized for severe pneumon
Externí odkaz:
https://doaj.org/article/f4d73d17d94a4ea2bb609bb111805efd
Autor:
Fabio Stagno, Elisabetta Abruzzese, Alessandra Iurlo, Fabrizio Pane, Imma Attolico, Paolo Sportoletti, Patrizia Pregno, Sara Galimberti, Barbara Scappini, Maurizio Miglino, Sergio Siragusa, Isabella Capodanno, Diletta Valsecchi, Aurelio Pio Nardozza, Paola Coco, Gianantonio Rosti, Giuseppe Saglio, Massimo Breccia
Publikováno v:
Blood. 140:9614-9616
Autor:
Massimo Breccia, Francesca Chiodi, Aurelio Pio Nardozza, Diletta Valsecchi, Valentina Perrone, Diego Sangiorgi, Elisa Giacomini, Maria Chiara Rendace, Paola Coco, Eleonora Premoli, Luca Degli Esposti
Publikováno v:
Advances in therapy.
Chronic myeloid leukemia (CML) is a hematopoietic myeloproliferative disorder that accounts for 20% of all leukemias of adults. The introduction of tyrosine kinase inhibitors (TKIs) (imatinib, bosutinib, dasatinib, nilotinib, ponatinib) has yielded s
Autor:
Gianantonio Rosti, Giuseppe Saglio, Fabio Stagno, Diletta Valsecchi, Aurelio Pio Nardozza, Paola Coco, Massimo Breccia, Alessandra Iurlo
Publikováno v:
Blood. 140:9643-9644
Autor:
Vincenzo Pavone, Paola Guglielmelli, Francesca Palandri, Patrizio Mazza, Giuseppe A. Palumbo, Diletta Valsecchi, Francesco Mendicino, Massimo Breccia, Stefana Impera, Francesco Passamonti, Daniela Cilloni, Marco Santoro, Domenico Pastore, Carmine Selleri, Paola Coco, Mara Morelli
Publikováno v:
Leukemialymphoma. 63(1)
ROMEI, a prospective, observational study in patients with myelofibrosis receiving the oral JAK1/2 inhibitor ruxolitinib in real-world practice, assesses treatment adherence based on the 8-item Morisky Medication Adherence Scale (MMAS-8). Here, we pr
Autor:
Carole Paley, Maria Rita Badagliacca, Paolo A. Ascierto, Andrea D’Alessio, Alberto Tedeschi, Moreno Festuccia, Andrea Mortara, Mauro Turrini, Enrico Capochiani, Annalisa Saracino, Federico Simonetti, Alessandro M. Vannucchi, Alfredo Molteni, Giuseppe Saglio, Paola Coco, Roberto Palazzolo, Davide Rapezzi, Katia Falasca, Antonella d'Arminio Monforte, Mara Morelli, Carmine Selleri, Mike Zuurman, Monica Bocchia, Giuliano Schettino
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 16
Journal of Clinical Medicine, Vol 10, Iss 3752, p 3752 (2021)
Volume 10
Issue 16
Journal of Clinical Medicine, Vol 10, Iss 3752, p 3752 (2021)
Jak inhibitors are potent anti-inflammatory drugs that have the potential to dampen the hyperactive inflammatory response associated with severe COVID-19. We reviewed the clinical outcomes of 218 patients with COVID-19 hospitalized for severe pneumon
Autor:
Paola Guglielmelli, Francesca Palandri, Carmine Selleri, Daniela Cilloni, Francesco Mendicino, Patrizio Mazza, Domenico Pastore, Giuseppe A. Palumbo, Marco Santoro, Vincenzo Pavone, Stefana Impera, Mara Morelli, Paola Coco, Diletta Valsecchi, Francesco Passamonti, Massimo Breccia, ROMEI Study Group
Publikováno v:
SSRN Electronic Journal.
Autor:
Valentina Perrone, Diego Sangiorgi, Maria Chiara Rendace, Elisa Giacomini, Eleonora Premoli, Paola Coco, Luca Degli Esposti, Francesca Chiodi, Massimo Breccia, Diletta Valsecchi
Publikováno v:
Blood. 138:1943-1943
Background The use of real-world data in oncology is gaining increasing interest, as it can provide valuable insights into treatments and related outcomes in routine daily oncology practice, thus integrating the evidence coming from clinical trials.